HESI Pharmacology Exam 2025/2026 300+
Verified Questions and Answers |
Comprehensive HESI Pharmacology Study
Guide, Practice Test Bank, Detailed Rationales
for Nursing Students Preparing for HESI
Pharmacology Exam, NCLEX Readiness, and
Medication Management Mastery
Question 1: A nurse is preparing to administer a medication that follows first-order kinetics. Which
statement best describes this pharmacokinetic principle?
A. The drug is eliminated at a constant rate regardless of concentration
B. The drug's elimination rate is proportional to its plasma concentration
C. The drug reaches steady state after exactly two half-lives
D. The drug's bioavailability is always 100%
CORRECT ANSWER: B. The drug's elimination rate is proportional to its plasma concentration
RATIONALE: First-order kinetics means that a constant fraction of the drug is eliminated per unit of
time, so the elimination rate is directly proportional to the drug's plasma concentration. This is the most
common elimination pattern for medications. Option A describes zero-order kinetics, where a constant
amount is eliminated regardless of concentration. Option C is incorrect because steady state is typically
reached after 4-5 half-lives. Option D is incorrect because bioavailability varies based on route of
administration and first-pass metabolism.
Question 2: When teaching a patient about a medication with a narrow therapeutic index, which
information is the nurse's priority?
A. The medication should be taken with food to enhance absorption
B. Regular laboratory monitoring is essential to ensure safe drug levels
C. The medication may cause drowsiness, so driving should be avoided
D. The medication should be stored at room temperature away from light
CORRECT ANSWER: B. Regular laboratory monitoring is essential to ensure safe drug levels
RATIONALE: Medications with a narrow therapeutic index have a small margin between therapeutic
and toxic doses, making regular laboratory monitoring critical to prevent toxicity while ensuring efficacy.
Examples include warfarin, digoxin, and lithium. While options A, C, and D may be relevant for specific
medications, they are not the priority teaching point for all drugs with a narrow therapeutic index.
Question 3: A patient receiving an intravenous medication develops redness, swelling, and pain at the
infusion site. The nurse suspects extravasation of a vesicant drug. What is the priority nursing action?
A. Apply a warm compress to the affected area
B. Stop the infusion immediately and aspirate any residual drug
,C. Elevate the extremity and document the findings
D. Administer an antihistamine as prescribed
CORRECT ANSWER: B. Stop the infusion immediately and aspirate any residual drug
RATIONALE: When extravasation of a vesicant medication is suspected, the priority action is to stop the
infusion immediately to prevent further tissue damage and aspirate any residual drug from the catheter
to minimize exposure. After this, specific antidotes or interventions may be applied based on the drug
involved. Applying warm or cold compresses depends on the specific vesicant, and documentation,
while important, is not the immediate priority.
Question 4: Which statement by a patient taking a CYP3A4 enzyme inducer indicates understanding of
potential drug interactions?
A. "I should avoid drinking grapefruit juice while taking this medication."
B. "This medication may decrease the effectiveness of my birth control pills."
C. "I need to take this medication on an empty stomach for best absorption."
D. "This drug will increase the sedative effects of my anxiety medication."
CORRECT ANSWER: B. "This medication may decrease the effectiveness of my birth control pills."
RATIONALE: CYP3A4 enzyme inducers (e.g., rifampin, phenytoin, carbamazepine) increase the
metabolism of other drugs processed by this enzyme system, potentially reducing their effectiveness.
Oral contraceptives are metabolized by CYP3A4, so their efficacy may be decreased. Option A refers to
CYP3A4 inhibitors like grapefruit juice. Option C relates to absorption, not enzyme induction. Option D
describes enzyme inhibition, not induction.
Question 5: A nurse is calculating a pediatric dose using the body surface area (BSA) method. The
child's BSA is 0.75 m², and the adult dose of the medication is 200 mg. What is the calculated pediatric
dose?
A. 75 mg
B. 87 mg
C. 100 mg
D. 150 mg
CORRECT ANSWER: B. 87 mg
RATIONALE: The BSA dosing formula is: Pediatric dose = (Child's BSA / 1.73 m²) × Adult dose.
Calculation: (0..73) × 200 mg = 0.4335 × 200 mg = 86.7 mg, which rounds to 87 mg. This method
provides more accurate dosing for children than weight-based calculations alone, especially for
medications with narrow therapeutic indices.
Question 6: Which pharmacodynamic concept explains why a patient may require increasingly higher
doses of an opioid analgesic to achieve the same pain relief over time?
A. Tolerance
B. Dependence
,C. Addiction
D. Tachyphylaxis
CORRECT ANSWER: A. Tolerance
RATIONALE: Tolerance is a pharmacodynamic phenomenon where repeated administration of a drug
leads to a diminished response, requiring higher doses to achieve the same therapeutic effect. This is
common with opioids, benzodiazepines, and other CNS depressants. Dependence refers to physiological
adaptation with withdrawal upon discontinuation. Addiction involves compulsive drug use despite harm.
Tachyphylaxis is rapid tolerance development after only a few doses.
Question 7: A patient is prescribed a medication that is highly protein-bound. Which condition would
most significantly increase the risk of drug toxicity?
A. Dehydration
B. Hypoalbuminemia
C. Hyperbilirubinemia
D. Polycythemia
CORRECT ANSWER: B. Hypoalbuminemia
RATIONALE: Highly protein-bound drugs (e.g., warfarin, phenytoin) circulate attached to albumin; only
the unbound fraction is pharmacologically active. In hypoalbuminemia, less protein is available for
binding, increasing the free drug concentration and risk of toxicity even at standard doses. Dehydration
may concentrate drugs but does not specifically affect protein binding. Hyperbilirubinemia and
polycythemia do not directly alter protein-binding capacity.
Question 8: When administering two ophthalmic medications to the same eye, what is the minimum
time interval the nurse should wait between instillations to prevent washout of the first medication?
A. 1 minute
B. 3 minutes
C. 5 minutes
D. 10 minutes
CORRECT ANSWER: C. 5 minutes
RATIONALE: A minimum 5-minute interval between ophthalmic medications allows adequate time for
absorption of the first medication and prevents the second drop from washing out the first. This ensures
optimal therapeutic effect of both agents. Shorter intervals may reduce efficacy, while longer intervals
are unnecessary and may decrease patient adherence.
Question 9: A patient receiving chemotherapy develops neutropenia. Which medication would the
nurse anticipate being prescribed to stimulate white blood cell production?
A. Epoetin alfa
B. Filgrastim
C. Oprelvekin
D. Darbepoetin alfa
, CORRECT ANSWER: B. Filgrastim
RATIONALE: Filgrastim is a granulocyte colony-stimulating factor (G-CSF) that stimulates the bone
marrow to produce neutrophils, making it the drug of choice for chemotherapy-induced neutropenia.
Epoetin alfa and darbepoetin alfa stimulate red blood cell production for anemia. Oprelvekin stimulates
platelet production for thrombocytopenia.
Question 10: Which statement accurately describes the difference between a drug's therapeutic effect
and its side effect?
A. Therapeutic effects are always desirable; side effects are always harmful
B. Therapeutic effects occur at lower doses; side effects occur only at toxic doses
C. Therapeutic effects are the intended pharmacological actions; side effects are unintended but
predictable actions
D. Therapeutic effects are mediated by receptors; side effects are non-receptor mediated
CORRECT ANSWER: C. Therapeutic effects are the intended pharmacological actions; side effects are
unintended but predictable actions
RATIONALE: Therapeutic effects are the desired pharmacological outcomes for which a medication is
prescribed. Side effects are secondary, unintended, but often predictable pharmacological actions that
may be harmless or bothersome. Option A is incorrect because some side effects may be beneficial in
other contexts. Option B is incorrect because side effects can occur at therapeutic doses. Option D is
incorrect because both effects can be receptor-mediated.
Question 11: A patient with renal impairment is prescribed a medication that is primarily eliminated
by the kidneys. What adjustment should the nurse anticipate?
A. Increased dosing frequency
B. Higher individual doses
C. Reduced dose or extended dosing interval
D. Switching to intravenous administration
CORRECT ANSWER: C. Reduced dose or extended dosing interval
RATIONALE: In renal impairment, drugs eliminated primarily by the kidneys accumulate, increasing
toxicity risk. Dosing adjustments typically involve reducing the dose, extending the dosing interval, or
both, based on the drug's pharmacokinetics and the patient's creatinine clearance. Increasing dose or
frequency would worsen accumulation. Route change does not address elimination impairment.
Question 12: Which route of medication administration provides the most rapid onset of action?
A. Oral
B. Subcutaneous
C. Intramuscular
D. Intravenous
CORRECT ANSWER: D. Intravenous
Verified Questions and Answers |
Comprehensive HESI Pharmacology Study
Guide, Practice Test Bank, Detailed Rationales
for Nursing Students Preparing for HESI
Pharmacology Exam, NCLEX Readiness, and
Medication Management Mastery
Question 1: A nurse is preparing to administer a medication that follows first-order kinetics. Which
statement best describes this pharmacokinetic principle?
A. The drug is eliminated at a constant rate regardless of concentration
B. The drug's elimination rate is proportional to its plasma concentration
C. The drug reaches steady state after exactly two half-lives
D. The drug's bioavailability is always 100%
CORRECT ANSWER: B. The drug's elimination rate is proportional to its plasma concentration
RATIONALE: First-order kinetics means that a constant fraction of the drug is eliminated per unit of
time, so the elimination rate is directly proportional to the drug's plasma concentration. This is the most
common elimination pattern for medications. Option A describes zero-order kinetics, where a constant
amount is eliminated regardless of concentration. Option C is incorrect because steady state is typically
reached after 4-5 half-lives. Option D is incorrect because bioavailability varies based on route of
administration and first-pass metabolism.
Question 2: When teaching a patient about a medication with a narrow therapeutic index, which
information is the nurse's priority?
A. The medication should be taken with food to enhance absorption
B. Regular laboratory monitoring is essential to ensure safe drug levels
C. The medication may cause drowsiness, so driving should be avoided
D. The medication should be stored at room temperature away from light
CORRECT ANSWER: B. Regular laboratory monitoring is essential to ensure safe drug levels
RATIONALE: Medications with a narrow therapeutic index have a small margin between therapeutic
and toxic doses, making regular laboratory monitoring critical to prevent toxicity while ensuring efficacy.
Examples include warfarin, digoxin, and lithium. While options A, C, and D may be relevant for specific
medications, they are not the priority teaching point for all drugs with a narrow therapeutic index.
Question 3: A patient receiving an intravenous medication develops redness, swelling, and pain at the
infusion site. The nurse suspects extravasation of a vesicant drug. What is the priority nursing action?
A. Apply a warm compress to the affected area
B. Stop the infusion immediately and aspirate any residual drug
,C. Elevate the extremity and document the findings
D. Administer an antihistamine as prescribed
CORRECT ANSWER: B. Stop the infusion immediately and aspirate any residual drug
RATIONALE: When extravasation of a vesicant medication is suspected, the priority action is to stop the
infusion immediately to prevent further tissue damage and aspirate any residual drug from the catheter
to minimize exposure. After this, specific antidotes or interventions may be applied based on the drug
involved. Applying warm or cold compresses depends on the specific vesicant, and documentation,
while important, is not the immediate priority.
Question 4: Which statement by a patient taking a CYP3A4 enzyme inducer indicates understanding of
potential drug interactions?
A. "I should avoid drinking grapefruit juice while taking this medication."
B. "This medication may decrease the effectiveness of my birth control pills."
C. "I need to take this medication on an empty stomach for best absorption."
D. "This drug will increase the sedative effects of my anxiety medication."
CORRECT ANSWER: B. "This medication may decrease the effectiveness of my birth control pills."
RATIONALE: CYP3A4 enzyme inducers (e.g., rifampin, phenytoin, carbamazepine) increase the
metabolism of other drugs processed by this enzyme system, potentially reducing their effectiveness.
Oral contraceptives are metabolized by CYP3A4, so their efficacy may be decreased. Option A refers to
CYP3A4 inhibitors like grapefruit juice. Option C relates to absorption, not enzyme induction. Option D
describes enzyme inhibition, not induction.
Question 5: A nurse is calculating a pediatric dose using the body surface area (BSA) method. The
child's BSA is 0.75 m², and the adult dose of the medication is 200 mg. What is the calculated pediatric
dose?
A. 75 mg
B. 87 mg
C. 100 mg
D. 150 mg
CORRECT ANSWER: B. 87 mg
RATIONALE: The BSA dosing formula is: Pediatric dose = (Child's BSA / 1.73 m²) × Adult dose.
Calculation: (0..73) × 200 mg = 0.4335 × 200 mg = 86.7 mg, which rounds to 87 mg. This method
provides more accurate dosing for children than weight-based calculations alone, especially for
medications with narrow therapeutic indices.
Question 6: Which pharmacodynamic concept explains why a patient may require increasingly higher
doses of an opioid analgesic to achieve the same pain relief over time?
A. Tolerance
B. Dependence
,C. Addiction
D. Tachyphylaxis
CORRECT ANSWER: A. Tolerance
RATIONALE: Tolerance is a pharmacodynamic phenomenon where repeated administration of a drug
leads to a diminished response, requiring higher doses to achieve the same therapeutic effect. This is
common with opioids, benzodiazepines, and other CNS depressants. Dependence refers to physiological
adaptation with withdrawal upon discontinuation. Addiction involves compulsive drug use despite harm.
Tachyphylaxis is rapid tolerance development after only a few doses.
Question 7: A patient is prescribed a medication that is highly protein-bound. Which condition would
most significantly increase the risk of drug toxicity?
A. Dehydration
B. Hypoalbuminemia
C. Hyperbilirubinemia
D. Polycythemia
CORRECT ANSWER: B. Hypoalbuminemia
RATIONALE: Highly protein-bound drugs (e.g., warfarin, phenytoin) circulate attached to albumin; only
the unbound fraction is pharmacologically active. In hypoalbuminemia, less protein is available for
binding, increasing the free drug concentration and risk of toxicity even at standard doses. Dehydration
may concentrate drugs but does not specifically affect protein binding. Hyperbilirubinemia and
polycythemia do not directly alter protein-binding capacity.
Question 8: When administering two ophthalmic medications to the same eye, what is the minimum
time interval the nurse should wait between instillations to prevent washout of the first medication?
A. 1 minute
B. 3 minutes
C. 5 minutes
D. 10 minutes
CORRECT ANSWER: C. 5 minutes
RATIONALE: A minimum 5-minute interval between ophthalmic medications allows adequate time for
absorption of the first medication and prevents the second drop from washing out the first. This ensures
optimal therapeutic effect of both agents. Shorter intervals may reduce efficacy, while longer intervals
are unnecessary and may decrease patient adherence.
Question 9: A patient receiving chemotherapy develops neutropenia. Which medication would the
nurse anticipate being prescribed to stimulate white blood cell production?
A. Epoetin alfa
B. Filgrastim
C. Oprelvekin
D. Darbepoetin alfa
, CORRECT ANSWER: B. Filgrastim
RATIONALE: Filgrastim is a granulocyte colony-stimulating factor (G-CSF) that stimulates the bone
marrow to produce neutrophils, making it the drug of choice for chemotherapy-induced neutropenia.
Epoetin alfa and darbepoetin alfa stimulate red blood cell production for anemia. Oprelvekin stimulates
platelet production for thrombocytopenia.
Question 10: Which statement accurately describes the difference between a drug's therapeutic effect
and its side effect?
A. Therapeutic effects are always desirable; side effects are always harmful
B. Therapeutic effects occur at lower doses; side effects occur only at toxic doses
C. Therapeutic effects are the intended pharmacological actions; side effects are unintended but
predictable actions
D. Therapeutic effects are mediated by receptors; side effects are non-receptor mediated
CORRECT ANSWER: C. Therapeutic effects are the intended pharmacological actions; side effects are
unintended but predictable actions
RATIONALE: Therapeutic effects are the desired pharmacological outcomes for which a medication is
prescribed. Side effects are secondary, unintended, but often predictable pharmacological actions that
may be harmless or bothersome. Option A is incorrect because some side effects may be beneficial in
other contexts. Option B is incorrect because side effects can occur at therapeutic doses. Option D is
incorrect because both effects can be receptor-mediated.
Question 11: A patient with renal impairment is prescribed a medication that is primarily eliminated
by the kidneys. What adjustment should the nurse anticipate?
A. Increased dosing frequency
B. Higher individual doses
C. Reduced dose or extended dosing interval
D. Switching to intravenous administration
CORRECT ANSWER: C. Reduced dose or extended dosing interval
RATIONALE: In renal impairment, drugs eliminated primarily by the kidneys accumulate, increasing
toxicity risk. Dosing adjustments typically involve reducing the dose, extending the dosing interval, or
both, based on the drug's pharmacokinetics and the patient's creatinine clearance. Increasing dose or
frequency would worsen accumulation. Route change does not address elimination impairment.
Question 12: Which route of medication administration provides the most rapid onset of action?
A. Oral
B. Subcutaneous
C. Intramuscular
D. Intravenous
CORRECT ANSWER: D. Intravenous
